Tonix Pharmaceuticals Holding Corp
TNXP
Market Cap$235.28M
Close$
$21.31
39% downside
Current Fair Value
39% downsideOvervalued by 39% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $235.28 Million |
|---|---|
| Enterprise Value | $108.32 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3504 |
| Beta | 2.11 |
| Outstanding Shares | 5,927,231 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.65 |
|---|---|
| PEG | 1.65 |
| Price to Sales | 34.92 |
| Price to Book Ratio | 1.16 |
| Enterprise Value to Revenue | 10.79 |
| Enterprise Value to EBIT | -1.5 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Tonix Pharmaceuticals Holding Corp
CEO: Seth Lederman